Search

Your search keyword '"Minervini, Fabrizio"' showing total 49 results
Start Over Author "Minervini, Fabrizio" Publisher ame publishing company
49 results on '"Minervini, Fabrizio"'

3. Benign tumors of the chest wall

Author

Minervini, Fabrizio, primary, Sergi, Consolato Maria, additional, Scarci, Marco, additional, Kestenholz, Peter B., additional, Valentini, Leonardo, additional, Boschetti, Laura, additional, and Bertoglio, Pietro, additional

Published
2024
Full Text
View/download PDF

12. Adjuvant treatment for patients with incidentally resected limited disease small cell lung cancer—a retrospective study

Author

Jin, Kai-Qi, primary, Liu, Xiao-Gang, additional, Guo, Yan-Hua, additional, Wu, Chun-Xiao, additional, Dai, Jie, additional, Li, Jia-Qi, additional, Minervini, Fabrizio, additional, Antonoff, Mara B., additional, Friedlaender, Alex, additional, Addeo, Alfredo, additional, Kocher, Gregor J., additional, Grossi, Francesco, additional, Zhu, Yu-Ming, additional, Zhang, Peng, additional, and Jiang, Ge-Ning, additional

Published
2022
Full Text
View/download PDF

13. Expert consensus on perioperative treatment for non-small cell lung cancer

Author

Duan, Jianchun, primary, Tan, Fengwei, additional, Bi, Nan, additional, Chen, Chun, additional, Chen, Ke-Neng, additional, Cheng, Ying, additional, Chu, Qian, additional, Ge, Di, additional, Hu, Jie, additional, Huang, Yunchao, additional, Jiang, Tao, additional, Long, Hao, additional, Lu, You, additional, Shi, Meiqi, additional, Wang, Jialei, additional, Wang, Qiming, additional, Yang, Fan, additional, Yang, Nong, additional, Yao, Yu, additional, Ying, Jianming, additional, Zhou, Caicun, additional, Zhou, Qing, additional, Zhou, Qinghua, additional, Bongiolatti, Stefano, additional, Brunelli, Alessandro, additional, Fiorelli, Alfonso, additional, Gobbini, Elisa, additional, Gridelli, Cesare, additional, John, Thomas, additional, Kim, Jae Jun, additional, Lin, Steven H., additional, Metro, Giulio, additional, Minervini, Fabrizio, additional, Novoa, Nuria M., additional, Owen, Dwight H., additional, Rodriguez, Maria, additional, Sakanoue, Ichiro, additional, Scarci, Marco, additional, Suda, Kenichi, additional, Tabbò, Fabrizio, additional, Tam, Terence Chi Chun, additional, Tsuchida, Masanori, additional, Uchino, Junji, additional, Voltolini, Luca, additional, Wang, Jie, additional, and Gao, Shugeng, additional

Published
2022
Full Text
View/download PDF

18. Thymic tumours: a single center surgical experience and literature review on the current diagnosis and management of thymic malignancies

Author

Minervini, Fabrizio, primary, Boschetti, Laura, additional, Gregor, Michael, additional, Provencio, Mariano, additional, Calvo, Virginia, additional, Kestenholz, Peter B., additional, Lampridis, Savvas, additional, Patrini, Davide, additional, Bertoglio, Pietro, additional, Azenha, L. Filipe, additional, Sergi, Consolato M., additional, and Kocher, Gregor J., additional

Published
2021
Full Text
View/download PDF

20. Pneumonectomy for lung cancer in the elderly: lessons learned from a multicenter study

Author

Minervini, Fabrizio, primary, Kocher, Gregor J., additional, Bertoglio, Pietro, additional, Kestenholz, Peter B., additional, Muñoz, Carlos Gálvez, additional, Patrini, Davide, additional, Ceulemans, Laurens J., additional, Begum, Housne, additional, Lutz, Jon, additional, Shojai, Max, additional, Shargall, Yaron, additional, and Scarci, Marco, additional

Published
2021
Full Text
View/download PDF

27. The efficacy and safety of albumin-bound paclitaxel plus carboplatin as neoadjuvant therapy for potentially resectable lung squamous cell carcinoma: a real-world retrospective cohort study

Author

Jiang, Wenjuan, primary, Zhou, Yuling, additional, Zeng, Liang, additional, Xiong, Yi, additional, Liu, Li, additional, Zhou, Chunhua, additional, Yang, Haiyan, additional, Guo, Hui, additional, Minervini, Fabrizio, additional, Bongiolatti, Stefano, additional, Yang, Nong, additional, Zhang, Yongchang, additional, and Tao, Min, additional

Published
2021
Full Text
View/download PDF

33. Learning points in chest wall trauma management

Author

Patrini, Davide, primary, Lawrence, David, additional, Lampridis, Savvas, additional, Minervini, Fabrizio, additional, Giorgi, Lorenzo, additional, Palermo, Roberto, additional, Hayward, Martin, additional, Scarci, Marco, additional, Schmidt, Joachim, additional, and Bedetti, Benedetta, additional

Published
2020
Full Text
View/download PDF

39. Pediatric chest trauma

Author

Minervini, Fabrizio, primary, Scarci, Marco, additional, Kocher, Gregor J., additional, Kestenholz, Peter B., additional, and Bertoglio, Pietro, additional

Published
2019
Full Text
View/download PDF

47. Robotic-assisted thoracoscopic surgery first rib resection-surgical technique.

Author

Minervini F, Kestenholz P, Scarci M, and Mayer N

Abstract

Thoracic outlet syndrome (TOS) is a rare condition resulting from the compression of the brachial plexus and/or the subclavian vessels in the thoracic outlet (TO). Neurogenic TOS (NTOS) is the most common form in up to 95% of the cases, while venous TOS (VTOS) occurs in 3-5% and arterial TOS (ATOS) in 1-2% of the cases. Patients may suffer from the pathologic coexistence of arterio-venous compression in the TO called arterio-venous TOS (AVTOS) with an overlap of clinical symptoms. While imaging studies such as computed tomography (CT)-angiography, magnetic resonance imaging (MRI)-angiography and duplex sonography are helpful to detect the underlying condition in vascular pathologies, electrodiagnostic testing is necessary to distinguish NTOS from other peripheral neuropathies. Subclavian vein (SV)-compression in the TO can result in venous thrombosis, called Paget-Schroetter syndrome (PSS), named after the discoverers of the disease. Besides oral anticoagulation in cases with venous upper extremity thrombosis and multimodal conservative treatment in the management of NTOS, surgical decompression is the current standard of care for TOS. Surgical decompression aims to remove structures compressing the brachial plexus or the subclavian vasculature in the TO. In NTOS, when conservative management has failed, surgical resection of the 1 st or a cervical rib is often combined with scalenectomy and brachial plexus neurolysis. Minimally invasive techniques have replaced traditionally open supra-, infraclavicular or transaxillary approaches with excellent results and minimal morbidity. Video-assisted thoracoscopic surgery (VATS) was described to offer better visualization, shorter length of stay (LOS) and less neurovascular injuries attributable to less traction applied. Robotic-assisted thoracoscopic surgery (RATS) moreover, further improved magnification, angulation of the surgical instruments in narrow anatomical spaces and the comfort for the operating surgeon. Uniportal RATS (uRATS) has lately been applied for 1 st rib resection. The aim of this surgical technique manual is to describe and illustrate a RATS 1 st rib resection with its advantages over traditionally open approaches step by step., Competing Interests: Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-24-702/coif). The authors have no conflicts of interest to declare., (2024 AME Publishing Company. All rights reserved.)

Published
2024
Full Text
View/download PDF

48. Surgical access to the mediastinum- all roads lead to Rome : a literature review.

Author

Mayer N, Kestenholz P, and Minervini F

Abstract

Background and Objective: The mediastinum is a complex, heterogeneous area, which leads vertically across the thoracic cavity between the bilateral mediastinal pleurae, connecting the head and neck region with the thoracic cavity. Different classifications have been published to differentiate between the so-called mediastinal compartments while the most used classification surely is the 4-compartments Gray`s classification, dividing it into the superior, anterior, middle and posterior mediastinum. Mediastinal abnormalities include infections (mediastinitis) and solid or cystic mediastinal masses. These masses can be divided into benign and malignant lesions originating from mediastinal structures/organs or represent manifestations of metastatic disease, often metastatic non-small cell lung cancer (NSCLC). This review aims to explore the different mediastinal pathologies along with indications and surgical approaches., Methods: We performed literature research in PubMed, MEDLINE, Embase, CENTRAL, and CINAHL databases. Only papers written in English were included., Key Content and Findings: Depending on the indication for surgical intervention and the localization of the pathology, surgical approach may differ immensely. Mediastinal staging of lung cancer, primary lesions of the mediastinum, mediastinitis and traumatic mediastinal injuries display the most frequent indications for mediastinal surgery. Surgical approaches trend towards minimally invasive, video- or robotic-assisted techniques and are becoming increasingly refined to adapt to the special characteristics of the mediastinum. However, certain indications still require open access for best possible mediastinal exposure or oncological reasons., Conclusions: To guide optimal surgical approach selection to the mediastinum, the following overview will present all published surgical approaches to the mediastinum and discuss their practical relevance and indications aiming to help surgeons in the management of patients with mediastinal pathologies who should undergo surgery., Competing Interests: Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://med.amegroups.com/article/view/10.21037/med-23-71/coif). The authors have no conflicts of interest to declare., (2024 Mediastinum. All rights reserved.)

Published
2024
Full Text
View/download PDF

49. Stage III-IV thymic squamous cell carcinoma in complete pathological remission achieved with thymic cancer resection after immunotherapy combined with chemotherapeutic conversion therapy: a report of two cases from real-world data.

Author

Li D, Minervini F, Planas G, Okuda K, Ozeki N, and Zou Y

Abstract

Background: Thymic carcinoma, a rare malignancy in the mediastinum, currently lacks standardized treatment options. Although surgery remains a crucial component among traditional therapeutic approaches, the potential benefits of radiotherapy and chemotherapy remain controversial. Nevertheless, a substantial number of patients are diagnosed with advanced tumor growth, posing challenges for achieving complete resection through surgical intervention and resulting in a poor prognosis. In light of the promising antitumor effects demonstrated by immunotherapy in various prevalent cancers, certain studies have shown favorable efficacy in advanced or recurrent thymic cancer cases. However, the incidence of adverse effects induced by immunotherapy in thymic cancer is notably higher compared to other tumor types, with severe and fatal complications being particularly significant. Consequently, there is an urgent need to address the crucial issue of patient selection for immunotherapy in thymic cancer., Case Description: In this study, we report on the treatment with programmed cell death protein 1 (PD-1) inhibitor therapy combined with chemotherapy conversion therapy for two patients diagnosed with stage III-IV thymic squamous cell carcinoma according to the Masaoka-Koga staging system. The aim of this study was to assess the effectiveness and safety of PD-1 inhibitor combined with chemotherapy conversion therapy in patients with thymic squamous cell carcinoma. Two patients in this cohort, one with stage III and another with stage IV disease, were deemed ineligible for upfront surgical resection. Puncture pathology confirmed the diagnosis of thymic squamous cell carcinoma. Both patients underwent transformation therapy using a combination of PD-1 inhibitors and chemotherapy. Tumor shrinkage was observed in both patients, enabling successful completion of surgery. Postoperative pathology revealed no residual tumor cells, indicating complete pathological remission. Notably, none of the patients experienced grade 3 or higher immunotherapy-related adverse reactions following immunotherapy., Conclusions: A combination of PD-1 inhibitors and chemotherapy followed by surgery demonstrated improved efficacy and enhanced safety for treating patients with Masaoka-Koga stage III-IV thymic squamous carcinoma and represents a potential novel therapeutic alternative for this disease., Competing Interests: Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://gs.amegroups.com/article/view/10.21037/gs-23-488/coif). The authors have no conflicts of interest to declare., (2024 Gland Surgery. All rights reserved.)

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results